secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001628280-24-027028
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive Therapeutics promotes Cassie Jung to COO effective June 3, 2024
-------------------------------------------------------------------------

- Cassie Jung, 45, promoted to Chief Operating Officer, effective June 3, 2024.
- Jung joined Aquestive in 2004 and served as VP Operations since 2019.
- Annual base salary increased to $349,800; target incentive at least 40% of base.
- No family relationships with directors/officers or reportable transactions.
- Employment agreement will be filed with next 10-Q.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024027028/0001628280-24-027028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024027028/aqst-20240603.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-027028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer